The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene; Eisai; Genentech; Genomic Health; Novartis; Pfizer; Puma Biotechnology
Consulting or Advisory Role - Amgen; AstraZeneca; Athenex; Celldex; Eisai; Puma Biotechnology
Research Funding - Eisai
EMERALD: A randomized, open label, phase III trial to evaluate the efficacy and safety of elacestrant (RAD1901) versus investigator’s choice (IC) of endocrine therapy (ET) for ER+/HER2- advanced breast cancer (BC) following CDK4/6 inhibitor (CDK4/6i) therapy.
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Merck (Inst); Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - bioTheranostics
 
Philippe Georges Aftimos
Honoraria - Roche; Synthon
Consulting or Advisory Role - Amcure; Amgen; Boehringer Ingelheim; Macrogenics; Novartis; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; MSD Oncology; Pfizer; Roche Belgium
 
Hai Jiang
Employment - Radius Health
Stock and Other Ownership Interests - Radius Health
 
Teeru Bihani
Employment - Radius Health
Stock and Other Ownership Interests - Radius Health
 
Alfred T Anderson-Villaluz
Employment - Radius Health
Consulting or Advisory Role - Scholar Rock; SynDevRx
Travel, Accommodations, Expenses - Radius Health
 
Maureen G. Conlan
Employment - Radius Health
 
Virginia G. Kaklamani
No Relationships to Disclose